The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 28, 2014
Filed:
Oct. 10, 2013
Applicant:
Vaxinnate Corporation, Cranbury, NJ (US);
Inventors:
Thomas J. Powell, Cranbury, NJ (US);
Valerian Nakaar, Cranbury, NJ (US);
Langzhou Song, Cranbury, NJ (US);
James W. Huleatt, Cranbury, NJ (US);
William F. McDonald, Cranbury, NJ (US);
Duane D. Hewitt, Hamilton, CA;
Assignee:
Vaxinnate Corporation, Cranbury, NJ (US);
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/295 (2006.01); C07K 14/005 (2006.01); C07K 14/255 (2006.01); A61K 38/16 (2006.01); C07K 14/245 (2006.01); A61K 39/108 (2006.01); A61K 39/112 (2006.01); A61K 39/12 (2006.01);
U.S. Cl.
CPC ...
A61K 39/12 (2013.01); C07K 14/005 (2013.01); C07K 14/255 (2013.01); C12N 2770/24022 (2013.01); C12N 2770/24122 (2013.01); A61K 38/164 (2013.01); C07K 14/245 (2013.01); A61K 39/0258 (2013.01); A61K 39/0275 (2013.01); C07K 2319/00 (2013.01); A61K 38/162 (2013.01);
Abstract
Compositions that include at least a portion of at least one pathogen-associated molecular pattern and at least a portion of at least one member selected from the group consisting of a Den1 viral envelope protein, a Den2 viral envelope protein, a Den3 viral envelope protein and a Den4 viral envelope protein are employed in methods to stimulate a protective immune response in a subject.